CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers

(MedPage Today) -- A strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical hematopoietic stem-cell transplantation (HSCT), without graft-versus-host disease (GVHD) prophylaxis, is a feasible approach for patients...

https://www.medpagetoday.com/hematologyoncology/leukemia/109824

Source: MedPage Today Hematology/Oncology - April 24, 2024 Category: Hematology Source Type: news